These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14613441)

  • 21. Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
    Vakil N; Fennerty MB
    Am J Gastroenterol; 1996 Feb; 91(2):239-45. PubMed ID: 8607487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection.
    Sereni G; Azzolini F; Camellini L; Formisano D; Decembrino F; Iori V; Tioli C; Cavina M; Di Mario F; Bedogni G; Sassatelli R
    World J Gastroenterol; 2012 Sep; 18(33):4542-8. PubMed ID: 22969227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication.
    Gisbert JP; Marcos S; Gisbert JL; Pajares JM
    Helicobacter; 2001 Jun; 6(2):157-62. PubMed ID: 11422472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 'Rescue' therapies for the management of Helicobacter pylori infection.
    Di Mario F; Cavallaro LG; Scarpignato C
    Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial.
    Bahremand S; Nematollahi LR; Fourutan H; Tirgari F; Nouripour S; Mir E; Aghakhani S
    Eur J Gastroenterol Hepatol; 2006 May; 18(5):511-4. PubMed ID: 16607146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment.
    Puig I; Baylina M; Sánchez-Delgado J; López-Gongora S; Suarez D; García-Iglesias P; Muñoz N; Gisbert JP; Dacoll C; Cohen H; Calvet X
    J Antimicrob Chemother; 2016 Oct; 71(10):2740-53. PubMed ID: 27342548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vonoprazan improves the efficacy of Helicobacter pylori eradication therapy with a regimen consisting of clarithromycin and metronidazole in patients allergic to penicillin.
    Ono S; Kato M; Nakagawa S; Mabe K; Sakamoto N
    Helicobacter; 2017 Jun; 22(3):. PubMed ID: 28098408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
    Paoluzi P; Iacopini F; Crispino P; Nardi F; Bella A; Rivera M; Rossi P; Gurnari M; Caracciolo F; Zippi M; Pica R
    Helicobacter; 2006 Dec; 11(6):562-8. PubMed ID: 17083378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
    Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
    Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.
    Asaoka D; Nagahara A; Matsuhisa T; Takahashi S; Tokunaga K; Kawai T; Kawakami K; Suzuki H; Suzuki M; Nishizawa T; Kurihara N; Ito M; Sasaki H; Omata F; Mizuno S; Torii A; Ohkusa T; Mine T; Sakaki N
    Helicobacter; 2013 Dec; 18(6):468-72. PubMed ID: 23773231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
    Yurenev GL; Partzvania-Vinogradova EV; Andreev DN; Dicheva DT; Maiev IV
    Ter Arkh; 2018 Aug; 90(8):33-39. PubMed ID: 30701937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
    Gisbert JP; Marcos S; Gisbert JL; Pajares JM
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1303-7. PubMed ID: 11692055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.
    Gisbert JP; Perez-Aisa A; Rodrigo L; Molina-Infante J; Modolell I; Bermejo F; Castro-Fernández M; Antón R; Sacristán B; Cosme A; Barrio J; Harb Y; Gonzalez-Barcenas M; Fernandez-Bermejo M; Algaba A; Marín AC; McNicholl AG;
    Dig Dis Sci; 2014 Feb; 59(2):383-9. PubMed ID: 24126798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the dyspeptic patient: a cost-utility study.
    Ebell MH; Warbasse L; Brenner C
    J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An update on anti-Helicobacter pylori treatment in children.
    Khurana R; Fischbach L; Chiba N; Veldhuyzen van Zanten S
    Can J Gastroenterol; 2005 Jul; 19(7):441-5. PubMed ID: 16010308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study: Vonoprazan and proton pump inhibitors in
    Sakurai K; Suda H; Ido Y; Takeichi T; Okuda A; Hasuda K; Hattori M
    World J Gastroenterol; 2017 Jan; 23(4):668-675. PubMed ID: 28216974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan.
    Nishizawa T; Maekawa T; Watanabe N; Harada N; Hosoda Y; Yoshinaga M; Yoshio T; Ohta H; Inoue S; Toyokawa T; Yamashita H; Saito H; Kuwai T; Katayama S; Masuda E; Miyabayashi H; Kimura T; Nishizawa Y; Takahashi M; Suzuki H
    J Clin Gastroenterol; 2015 Jul; 49(6):468-71. PubMed ID: 24921211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial.
    Nguyen TV; Bengtsson C; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
    Helicobacter; 2008 Dec; 13(6):550-6. PubMed ID: 19166421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.